# Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

> **NCT02958345** · PHASE4 · COMPLETED · sponsor: **Tulane University** · enrollment: 28 (actual)

## Conditions studied

- Herpes Zoster
- Fibrosis

## Interventions

- **BIOLOGICAL:** Zostavax
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02958345
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02958345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02958345, "Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02958345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*